What does CytoDyn Inc do?

What does CytoDyn Inc do?

CytoDyn is a publicly traded late stage biotechnology company developing innovative treatments for multiple therapeutic indications based on Leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 appears to play a key role in the ability of HIV to enter and infect healthy T-cells.

Is Cydy a good stock?

The 1 analysts offering 12-month price forecasts for Cytodyn Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +1,076.47% increase from the last price of 0.34.

Where is CytoDyn located?

Vancouver, Washington
CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.

Why did Cydy drop today?

Shares of CytoDyn dropped after the biotech said the FDA sought more data, but didn’t require new trials, for its leronlimab treatment for HIV. Shares of CytoDyn (CYDY) – Get CytoDyn Inc.

What is CYDY stock price in Germany?


Exchange Last Bid
Stuttgart 0.3273
Berlin 0.3345
M√ľnchen 0.3293
gettex 0.3639 0.3263

How many employees does CytoDyn?

Latest Updates

Employees (est.) (Mar 2020) 10
Share Price (Apr 2022) $0.3 (+9%)
Cybersecurity rating A More

How can I buy CytoDyn stock?

How to buy shares in CytoDyn

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details.
  4. Research the stock.
  5. Purchase now or later.
  6. Check in on your investment.